Business Context and Reporting Period
This Form 8-K was filed by BioVie Inc. (formerly NanoAntibiotics, Inc.) on July 18, 2016. The report documents a special meeting of stockholders held on the same date to approve a corporate name change.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions rather than financial performance.
Material Changes
- Corporate Name Change: Stockholders approved an amendment to the Articles of Incorporation to change the company name from "NanoAntibiotics, Inc." to "BioVie Inc."
- Voting Results: The amendment was approved with 68,060,592 votes FOR and 0 votes AGAINST.
- Shareholder Participation: Stockholders representing 68,060,592 of the 87,160,001 issued and outstanding shares were present, establishing a quorum.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document is limited to the procedural details of the name change vote.
Investor Verification Checklist
- Verify the effective date of the name change with the Nevada Secretary of State.
- Confirm the updated ticker symbol and trading status on relevant exchanges following the name change.
- Review the Certificate of Amendment to Articles of Incorporation (Exhibit 3.1) for any additional provisions beyond the name change.
- Check subsequent filings for the first financial report issued under the new corporate name.